The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2003, Volume 27, Issue 9

The study presented in this article used a controlled-porosity osmotic pump, which was prepared in the form of a bilayered tablet containing a drug compartment and an osmogen layer for the delayed release of diltiazem HCI.

Related Content:

Drug DeliveryDevelopmentFormulation and Drug Delivery, Solid DosagePharmaceutical Technology-09-02-2003
With New Funding, Orbis Medicines to Develop Oral Macrocycles as Alternative to Biologic Drugs
Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia
Roche Forms Partnership Worth Potentially More than $1 Billion with Innovent to Develop Novel ADC for SCLC